Carbamazepine induced erythroderma with systemic lymphadenopathy

Ryuhei Okuyama, Ryo Ichinohasama, Hachiro Tagami

研究成果: Article査読

17 被引用数 (Scopus)

抄録

We describe a 13-year-old girl with carbamazepine (CBZ)-induced erythroderma associated with marked generalized lymphadenopathy, a very rare form of CBZ hypersensitivity. The results of lymphocyte stimulation test (LST) and patch testing provided valuable evidence for distinguishing CBZ hypersensitivity from immunoblastic lymphadenopathy (IBL) and infectious mononucleosis (IM). An increased LST value was the only clue leading us to suspect a hypersensitivity reaction against CBZ at a peak stage of the skin eruption. In contrast, CBZ patch testing, which was negative at that time, became positive when the erythroderma regressed after discontinuation of CBZ. These findings suggest that LST can be a useful tool in diagnosing similar cases of hypersensitivity reactions to CBZ and other drugs, especially when patch test results are negative.

本文言語English
ページ(範囲)489-494
ページ数6
ジャーナルJournal of Dermatology
23
7
出版ステータスPublished - 1996 7

ASJC Scopus subject areas

  • Dermatology

フィンガープリント 「Carbamazepine induced erythroderma with systemic lymphadenopathy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル